CD274 and neoplasm: These hydrogels support the light‐controlled, sustained release of doxorubicin and anti‐PD‐L1, enhancing therapeutic outcomes through tumor microenvironment remodeling and showing better suppression efficacy for larger tumor models and distal tumors.